Symdeko OverviewTezacaftor, also known as VX-661, is a drug approved by the FDA to treat some cases of cystic fibrosis. In 2018, the FDA approved a combination of ivacaftor and tezacaftor; the manufacturer announced a list price of $292,000 per year. The combination of ivacaftor and tezacaftor is being sold as Symdeko. Contents 1 Mechanism of action 2 Properties 3 Clinical trials 4 References Mechanism of action Tezacaftor helps move the CFTR protein to the correct position on the cell surf...
Read more Symdeko Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tezacaftor
Recent Symdeko Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
Ivacaftor + Tezacaftor
- Tablet, Tablet: 150mg,n/a + 150mg, 100mg
NDC Database Records for Symdeko: (1 result)Sorted by National Drug Code
- 51167-661 Symdeko Kit by Vertex Pharmaceuticals Incorporated